Welcome to our dedicated page for Morgan Stanley SEC filings (Ticker: MS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Morgan Stanley (NYSE: MS) SEC filings page on Stock Titan brings together the firm’s regulatory disclosures, including current reports on Form 8‑K and other registered securities information. These filings show how Morgan Stanley communicates material events such as quarterly and annual financial results, capital actions, regulatory capital developments and securities offerings.
Form 8‑K filings frequently cover the release of financial information for specific quarters and for the full year, with press releases and financial data supplements filed as exhibits. Other 8‑K reports describe changes in the firm’s Stress Capital Buffer under the Federal Reserve’s supervisory stress testing framework, providing context on Morgan Stanley’s U.S. Basel III Standardized Approach Common Equity Tier 1 capital requirements.
The filings also list the securities registered under Section 12(b) of the Securities Exchange Act of 1934, including common stock, multiple series of non‑cumulative preferred stock represented by depositary shares, and global medium‑term notes issued by Morgan Stanley or Morgan Stanley Finance LLC, with Morgan Stanley acting as guarantor for certain notes. Additional 8‑K filings describe the approval of forms of master notes for global medium‑term notes and related legal opinions and consents.
On Stock Titan, these SEC documents are updated as they are made available on EDGAR. AI‑powered summaries help explain the key points in lengthy filings, so users can quickly see what each 8‑K, 10‑K or 10‑Q addresses without reading every page. Investors can also use this page to monitor registered securities, preferred stock disclosures and other regulatory information related to Morgan Stanley.
Morgan Stanley Finance LLC is offering structured notes linked to the SPDR® Gold Trust, fully and unconditionally guaranteed by Morgan Stanley. The notes have a $1,000 stated principal amount, pay no interest and mature on March 10, 2027.
At maturity, investors receive $1,000 plus 100% of any gain in the underlier, capped at a maximum payment of $1,127.60 per note. If the SPDR Gold Trust falls, principal is reduced 1% for each 1% decline but not below 95% of principal. The estimated value on the pricing date is approximately $982.30 per note, reflecting issuance, structuring and hedging costs, and all payments are subject to Morgan Stanley’s credit risk.
Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is offering principal-at-risk Jump Securities linked to the S&P 500® Index, priced at $1,000 per security. The estimated value on the pricing date is approximately $979.50 per security, reflecting issuing, selling, structuring and hedging costs.
The notes may be automatically redeemed on February 16, 2027 for an early redemption payment of $1,104.60 per security if the index on the first determination date is at or above the 6,798.40 call threshold. Otherwise, at maturity on February 10, 2028, investors receive upside at a 150% participation rate if the index rises, principal back if it is between 80% and 100% of the initial level, or a proportional loss if it falls below the 5,438.72 downside threshold, potentially losing the entire investment. All payments depend on Morgan Stanley’s credit and the notes will not be listed on any exchange.
Morgan Stanley Finance LLC is offering auto-callable, principal-at-risk notes linked to the worst performer of Citigroup, Goldman Sachs and Bank of America common stocks, maturing in February 2029 and fully and unconditionally guaranteed by Morgan Stanley.
Each $1,000 security pays a contingent coupon of at least 15.00% per annum, but only if on a quarterly observation date every stock closes at or above 70% of its starting price. After a six‑month non‑call period, the notes auto‑call at par plus coupon if all three stocks are at or above their starting prices.
If not called and any stock finishes below its 70% downside threshold at final valuation, investors are exposed 1‑for‑1 to the worst stock’s decline and can lose more than 30%, up to their entire principal. The issuer’s estimated value on the pricing date is about $961.50 per $1,000 security, versus a public offering price of $1,000 and dealer commissions of up to $23.25 per note, highlighting embedded fees and funding costs. The securities are unsecured obligations subject to Morgan Stanley’s credit risk and will not be listed; secondary liquidity may be limited.
Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is issuing principal-at-risk structured notes offering an 11.00% annual contingent coupon tied to the S&P® 500 Futures 40% Intraday 4% Decrement VT Index. Each security has a $1,000 stated principal amount and matures on February 11, 2031, with automatic early redemption possible starting in 2027 if the underlier closes at or above the call threshold level.
Coupons are paid only when the index closes at or above 70% of its initial level on observation dates, with missed coupons potentially paid later if the barrier is met. If held to maturity and the final index level is at least 50% of the initial level, investors receive principal back plus any due coupons; below 50%, repayment is reduced in line with the index decline and can fall to zero. The preliminary estimated value on the pricing date is approximately $895.20 per $1,000 note, reflecting issuance, structuring and hedging costs. The underlying index is a leveraged, volatility-targeting futures strategy with a 4.0% per annum decrement, which structurally drags performance, and all payments depend on Morgan Stanley’s credit.
Morgan Stanley Finance LLC is offering $1,000 principal-at-risk Callable Contingent Income Securities due November 18, 2030, fully and unconditionally guaranteed by Morgan Stanley and linked to the worst performing of the Dow Jones Industrial Average, Nasdaq-100 Index and S&P 500 Index.
The notes pay a 9.20% per annum contingent coupon only if on each observation date all three indexes are at or above 75% of their initial levels; otherwise no coupon is paid for that period. At maturity, if not called and each index is at or above 65% of its initial level, investors receive full principal; if any index is below 65%, repayment is reduced 1% for every 1% decline of the worst index, potentially to zero.
The notes are callable in whole, but not in part, on specified redemption dates starting August 18, 2026, based on a risk-neutral valuation model that favors redemption when it is economically rational for the issuer. The estimated value on the pricing date is approximately $977.30 per $1,000 security, reflecting issuance, structuring and hedging costs. All payments depend on Morgan Stanley’s credit and the notes will not be listed on any exchange.
Morgan Stanley Finance LLC is offering principal-at-risk contingent income auto-callable securities due February 8, 2029, fully and unconditionally guaranteed by Morgan Stanley. Each $1,000 note is linked to the EURO STOXX 50® Index, the Russell 2000® Index and Microsoft common stock, based on the worst-performing of the three.
The notes pay a contingent coupon at 10.75% per year, only if on each observation date all underliers are at or above their coupon barrier levels, set at 70% of initial levels. The securities can be auto-called on scheduled redemption determination dates if all underliers are at or above their call thresholds, equal to 100% of initial levels; in that case, investors receive principal plus the applicable coupon and the product terminates early.
If not called, and at maturity every underlier is at or above its 70% downside threshold, investors receive full principal back plus any final coupon. If any underlier finishes below its downside threshold, repayment is reduced 1% for each 1% decline in the worst-performing underlier, potentially to zero. The estimated value on the pricing date is approximately $950.30 per security, reflecting issuance, structuring and hedging costs and Morgan Stanley’s internal funding rate.
Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is offering $23,906,000 of Digital S&P 500® Index-Linked Notes maturing on March 8, 2027. These principal-at-risk notes pay no interest and the payout depends entirely on S&P 500® performance from the February 4, 2026 trade date to the March 4, 2027 determination date.
If the index finish level is at least 90% of the initial level of 6,882.72, investors receive a fixed maximum settlement of $1,085.70 per $1,000 note, equal to a 8.57% total return. If the index falls more than 10%, repayment is reduced using a downside formula with a buffer rate of about 111.11%, and losses can reach 100% of principal.
The original issue price is $1,000 per note, including selling, structuring and hedging costs, while the issuer’s estimated value on the trade date is $984.30. Morgan Stanley & Co. receives a 1.09% sales commission, and the notes are unsecured obligations exposed to Morgan Stanley’s credit risk with no listing or redemption feature.
Morgan Stanley Finance LLC is offering $2,751,000 of capped leveraged notes linked to the VanEck Gold Miners ETF, fully and unconditionally guaranteed by Morgan Stanley. The notes mature on March 8, 2027, pay no interest, and are principal-at-risk unsecured obligations.
At maturity, investors receive $1,000 plus 300% of any positive ETF return, capped at a maximum settlement of $1,542.10 per $1,000 face amount; any loss in the ETF is passed through one-for-one, with no minimum payment, so the entire investment can be lost. The initial ETF level is $98.70, the cap level is 118.07% of that, and the estimated value on the trade date is $979.90 per note versus the $1,000 issue price. Morgan Stanley & Co. earns a 0.95% selling concession, and all payments depend on Morgan Stanley’s credit.
Morgan Stanley has filed a Schedule 13G reporting a beneficial ownership stake in Ventyx Biosciences, Inc. common stock. Morgan Stanley reports aggregate beneficial ownership of 4,289,915 shares, representing 6.0% of the outstanding common stock as of the event date.
The firm reports shared voting and dispositive power over 2,285,401 shares and no sole voting or dispositive power. Morgan Stanley states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Ventyx Biosciences.
Morgan Stanley Finance LLC is offering Contingent Income Memory Auto-Callable Securities linked to the worst performing of the Nasdaq-100 Technology Sector Index, the Russell 2000 Index and the S&P 500 Index, fully and unconditionally guaranteed by Morgan Stanley.
The notes pay a contingent coupon at 10.75% per annum only when each index closes at or above its coupon barrier (80% of its initial level) on the relevant observation date, with missed coupons potentially paid later if conditions are met. The securities may be automatically called on scheduled dates if all three indices are at or above their call thresholds (100% of initial levels), returning principal plus due coupons.
If not called, and at maturity in 2031 any index finishes below its downside threshold (70% of initial level), repayment of principal is reduced in line with the decline of the worst index, potentially to zero. The estimated value on the pricing date is approximately $983.60 per $1,000 note, reflecting issuing, selling, structuring and hedging costs and Morgan Stanley’s internal funding rate. All payments are subject to Morgan Stanley’s credit risk and the notes will not be listed, so liquidity may be limited.